MedPath

Empowerment Intervention for Persons With Young Onset Dementia

Not Applicable
Completed
Conditions
Dementia
Empowerment
Interventions
Other: Empowerment intervention
Registration Number
NCT02937883
Lead Sponsor
Radboud University Medical Center
Brief Summary

The purpose of this study is to evaluate the effects of an empowerment intervention for community-dwelling persons with young onset dementia and their informal caregivers.

Detailed Description

This study focuses on the evaluation of an empowerment intervention developed for persons with young onset dementia and their informal caregivers. The empowerment intervention focuses on current capacities, maintenance of autonomy, and increasing the opportunities to feel useful. This pragmatic cluster randomized controlled trial aims to investigate (1) the effectiveness of the intervention concerning participants' well-being, quality of life, and behavioral issues, (2) the effect of the intervention on the informal caregivers' sense of competence and perceived distress, and (3) the impact of the intervention on healthcare costs. Furthermore, the investigators aim to study the feasibility of the intervention to frame an implementation strategy.

Participants in the intervention group will receive the intervention for 5 months. Participants of the control group receive care as usual.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosed with dementia before the age of 65
  • Living at home (community-dwelling)
Read More
Exclusion Criteria
  • Dementia is caused by Down's syndrome, Huntington's disease, HIV or alcohol-related dementia.
  • Limited contact between the person with dementia and the informal caregiver (<3 times a week)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
empowerment interventionEmpowerment interventionEmpowerment intervention
Primary Outcome Measures
NameTimeMethod
Changes in self-management abilities5 months

(Self-Management Ability Scale (SMAS))

Secondary Outcome Measures
NameTimeMethod
Changes in disability5 months

(Interview for Deterioration in Daily living activities in Dementia (IDDD))

Changes in quality of life5 months

(Quality of life - Alzheimer Disease scale (QOL-AD))

Changes in neuropsychiatric symptoms Questionnaire5 months

(Neuropsychiatric Inventory (NPI-Q))

Caregiver measures:Competence (5 months

Short Sense of Competence Questionnaire (SSCQ))

Changes in apathy5 months

(abbreviated Apathy Evaluation Scale (AES-10))

Caregiver measures: Emotional distress5 months

(NPI-Q distress score)

Trial Locations

Locations (1)

Florence

🇳🇱

Den Haag, Netherlands

© Copyright 2025. All Rights Reserved by MedPath